 |
PDBsum entry 3t6q
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immune system
|
PDB id
|
|
|
|
3t6q
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immune system
|
 |
|
Title:
|
 |
Crystal structure of mouse rp105/md-1 complex
|
|
Structure:
|
 |
Cd180 antigen. Chain: a, b. Fragment: unp residues 21-626. Synonym: lymphocyte antigen 78, ly-78, radioprotective 105 kda protein. Engineered: yes. Lymphocyte antigen 86. Chain: c, d. Synonym: ly-86, protein md-1.
|
|
Source:
|
 |
Mus musculus. Mouse. Organism_taxid: 10090. Gene: cd180, ly78, rp105. Expressed in: drosophila. Expression_system_taxid: 7215. Expression_system_cell: s2. Gene: ly86, md1. Expression_system_cell: s2
|
|
Resolution:
|
 |
|
1.90Å
|
R-factor:
|
0.188
|
R-free:
|
0.231
|
|
|
Authors:
|
 |
U.Ohto,T.Shimizu
|
|
Key ref:
|
 |
U.Ohto
et al.
(2011).
Crystal structures of mouse and human RP105/MD-1 complexes reveal unique dimer organization of the toll-like receptor family.
J Mol Biol,
413,
815-825.
PubMed id:
|
 |
|
Date:
|
 |
|
28-Jul-11
|
Release date:
|
09-Nov-11
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
J Mol Biol
413:815-825
(2011)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structures of mouse and human RP105/MD-1 complexes reveal unique dimer organization of the toll-like receptor family.
|
|
U.Ohto,
K.Miyake,
T.Shimizu.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The Toll-like receptor (TLR) 4/MD-2 heterodimer senses lipopolysaccharide (LPS).
RP105 (radioprotective 105 kDa), a TLR-related molecule, is similar to TLR4 in
that the extracellular leucine-rich repeats associate with MD-1, the MD-2-like
molecule. MD-2 has a unique hydrophobic cavity that directly binds to lipid A,
the active center of LPS. LPS-bound MD-2 opens the secondary interface with
TLR4, leading to dimerization of TLR4/MD-2. MD-1 also has a hydrophobic cavity
that accommodates lipid IVa, a precursor of lipid A, suggesting a role for the
RP105/MD-1 heterodimer in sensing LPS or related microbial products. Little is
known, however, about the structure of the RP105/MD-1 heterodimer or its
oligomer. Here, we have determined the crystal structures of mouse and human
RP105/MD-1 complexes at 1.9 and 2.8 Å resolutions, respectively. Both mouse and
human RP105/MD-1 exhibit dimerization of the 1:1 RP105/MD-1 complex,
demonstrating a novel organization. The "m"-shaped 2:2 RP105/MD-1
complex exhibits an inverse arrangement, with N-termini interacting in the
middle. Thus, the dimerization interface of RP105/MD-1 is located on the
opposite side of the complex, compared to the 2:2 TLR4/MD-2 complex. These
results demonstrate that the 2:2 RP105/MD-1 complex is distinct from previously
reported TLR dimers, including TLR4/MD-2, TLR1/TLR2, TLR2/TLR6, and TLR3, all of
which facilitate homotypic or heterotypic interaction of the C-terminal
cytoplasmic signaling domain.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
|